Product News and Recalls

Celiac Disease and the Brain

A recent New York Times piece looks at the effect of celiac disease on the brain. The story details what appeared to be sudden neurological or psychiatric symptoms, including seizures and hallucinations, that were eventually linked to patients’ celiac disease. The patients improved on a gluten-free diet after medications aimed at treating the neurologic symptoms failed.

Although celiac disease is notoriously difficult to diagnose, because of different symptoms among different patients, one study estimated that less than one ...

continue reading...

Quantification of Morcellation Cancer Risk

After much speculation about the risk of spreading cancer with power morcellators, a study published in the Journal of the American Medical Association has assembled information on this risk. The risk was quantified from a review of data from over 200,000 patients.

The medical records review showed that 36,470 women had procedures where the uterus was fragmented using morcellation. Of those, one in every 368 women had an undiagnosed uterine cancer, resulting in 99 patients, or about 0.27%, ...

continue reading...

D.E.A. to Permit the Return of Unused Prescription Drugs to Pharmacies

Amidst mounting nationwide concern over abuse of prescription drugs, the Drug Enforcement Agency (D.E.A.) has announced a new initiative to encourage the return of unused drugs to pharmacies. The new initiative seeks to reduce the quantity of prescription drugs that many consumers accumulate after they no longer need a medication.

Often times, patients are given prescriptions for more medication than necessary and thus end up with a stockpile of dangerous drugs. These drugs may be taken ...

continue reading...

Founding Partner James J. McHugh, Jr. to Speak at National Business Institute Seminar

Next month Lopez McHugh, LLP partner, James J. McHugh, Jr., will be part of a panel presenting a continuing legal education program for lawyers titled A Practical Guide to Federal Court: E-Discovery, Evidence and Experts. The program is being presented by the National Business Institute and will take place in Cherry Hill, NJ on December 18, 2014. Mr. McHugh will speak about ethical issues that arise in Federal Court including Federal Rule 11, sanctions in Federal Court ...

continue reading...

Pfizer’s Illegal Drug Marketing Charges Settle for $35 Billion

Pfizer subsidiary Wyeth settles marketing claims for 35 billion dollarsWyeth Pharmaceuticals, a subsidiary of Pfizer, was charged with illegally marketing a drug that was not cleared for use by the FDA. A story in the Sacramento Bee reports that Wyeth illegally marketed its organ transplant drug Rapamune for conditions it was not approved to treat.

The charges indicated that Wyeth trained and encouraged sales representatives to promote Rapamune for uses other than preventing rejection of kidney ...

continue reading...

$73 Million Awarded to Woman Injured by Boston Scientific Mesh Implant

After winning the first two trials over injuries allegedly caused by its Obtryx sling, Boston Scientific has been ordered to pay $73 million to a plaintiff in a Texas state court case. A Bloomberg story reports that this is the first award against this particular company because of a vaginal-mesh implant.

Boston Scientific was found liable for defectively designing its vaginal mesh sling. The plaintiff suffered from minor urine leakage when she received the Obtryx sling, ...

continue reading...
Page 1 of 212 12345...»